Anti-TNF-A Therapy about Infliximab and Adalimamab for the Effectiveness in Ulcerative Colitis Compared with Conventional Therapy: A Meta-Analysis.

Zheng ZhouCong DaiWei-xin Liu

Published in: Hepato-gastroenterology (2016)

Our meta-analyses suggested that Infliximab had a statistically significant effects in induction of clinical response of UC compared with conventional therapy and adalimumab had a statistically significant effects in induction of clinical remission and clinical response of UC compared with conventional therapy.

Keyphrases

ulcerative colitis
systematic review
randomized controlled trial
rheumatoid arthritis
meta analyses
systemic lupus erythematosus
mesenchymal stem cells
cell therapy